Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Accredo Health, Inc. (NasdaqNM:ACDO)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 16Earnings Announcement
Location
1640 Century Center Parkway, Suite 101
Memphis, TN 38134
Phone: (901) 385-3688
Fax: (901) 385-3776
Email: mhall@accredohealth.com
Employees (last reported count): 480
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Healthcare Facilities
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 12%
·Over the last 6 months:
 · 7 insider sells; 103.0K shares
  (3.2% of insider shares)
·Institutional: 95% (108% of float)
(305 institutions)
·Net Inst. Buying: 2.28M shares (+8.51%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Accredo Health, Incorporated provides specialized contract pharmacy and related services pursuant to agreements with biotechnology drug manufacturers relating to the treatment of patients with certain costly chronic diseases. The Company addresses the needs of the manufacturers by providing specialized services that facilitate product launch and patient acceptance including the collection of timely drug utilization and patient compliance information, patient education and monitoring through the use of written materials and telephonic consultation, reimbursement expertise and overnight drug delivery. The Company has designed its specialty services to focus primarily on biotechnology drugs that are used on a recurring basis to treat chronic, and potentially life threatening diseases, are expensive, are administered through injection, and require temperature control or other specialized handling as part of their distribution process.
More from Market Guide: Expanded Business Description

Financial Summary
Accredo Health, Inc. provides specialized contract pharmacy and related services pursuant to agreements with biotechnology drug manufacturers relating to the treatment of patients with certain costly, chronic diseases. For the fiscal year ended 6/30/01, revenues increased 31% to $462.1 million. Net Income increased 74% to $17.3 million. Results reflect growth in seasonal SYNAGIS drug sales and the acquisition of Pharmcare Resources, and the reduction of bad debt cost.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

David Stevens, 47
Chairman and CEO
$504K$2.5M
John Grow, 52
Pres
290K2.6M
Joel Kimbrough, 42
CFO, Sr. VP, Treasurer
285K1.1M
Kyle Callahan, 34
Sr. VP
278K--  
Thomas Bell, Jr., 49
Sr. VP, Gen. Counsel and Sec.
271K2.5M
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ACDOAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Oct-2000
$23.25 
Recent Price$36.85 
52-Week High
on 29-June-2001
$62.00 
Beta0.99 
Daily Volume (3-month avg)484.1K
Daily Volume (10-day avg)519.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+21.1%
52-Week Change
relative to S&P500
+62.5%
Share-Related Items
Market Capitalization$952.5M
Shares Outstanding25.8M
Float22.7M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 26-Feb-2001
Per-Share Data
Book Value (mrq)$7.31 
Earnings (ttm)$0.66 
Earnings (mrq)$0.18 
Sales (ttm)$17.69 
Cash (mrq)$2.18 
Valuation Ratios
Price/Book (mrq)5.04 
Price/Earnings (ttm)56.09 
Price/Sales (ttm)2.08 
Income Statements
Sales (ttm)$462.1M
EBITDA (ttm)$30.8M
Income available to common (ttm)$17.3M
Profitability
Profit Margin (ttm)3.7%
Operating Margin (ttm)5.7%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)6.67%
Return on Equity (ttm)10.83%
Financial Strength
Current Ratio (mrq)1.91 
Debt/Equity (mrq)0 
Total Cash (mrq)$56.5M
Short Interest
As of 8-Aug-2001
Shares Short1.81M
Percent of Float8.0%
Shares Short
(Prior Month)
1.60M
Short Ratio5.89 
Daily Volume308.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.